FDA approves Genentech oral Venclexta plus AstraZeneca's Calquence combination for first-line CLL

EMA validates Enhertu application for post-neoadjuvant HER2-positive early breast cancer

Merck reports positive Phase 3 data for Enflonsia in high-risk children across two RSV seasons

Hansa's imlifidase Biologics License Application accepted by FDA

Novartis reports positive Phase III results for remibrutinib in chronic inducible urticaria

Cambridge Cognition expands into India through Ivory commercialisation agreement

HanchorBio's HCB101 receives US FDA Orphan Drug Designation in gastric cancer

STADA and Bio-Thera Solutions receive European marketing authorisation for Gotenfia (golimumab)

MEDIPOST files IND amendment to start Phase III trial for knee osteoarthritis therapy

Pegasus Laboratories' KBroVet receives full FDA approval for control of seizures associated with IE in dogs

DifGen Pharmaceuticals' Fluorometholone Ophthalmic Suspension, 0.1% receives FDA approval

Philips launches InkSpace Imaging Snuggle coil for 3.0T MRI systems

Amgen wins European approval for Uplizna in generalised myasthenia gravis

Arctic Therapeutics enrols first patients in Phase IIa trial of AT-004 for acne vulgaris

BillionToOne launches two new add-on liquid biopsy applications for Northstar Select